In Silico Strategies in Tuberculosis Drug Discovery

SJY Macalino, JB Billones, VG Organo, MCO Carrillo - Molecules, 2020 - mdpi.com
Tuberculosis (TB) remains a serious threat to global public health, responsible for an
estimated 1.5 million mortalities in 2018. While there are available therapeutics for this …

Recent advances in the synthesis of glycoconjugates for vaccine development

C Colombo, O Pitirollo, L Lay - Molecules, 2018 - mdpi.com
During the last decade there has been a growing interest in glycoimmunology, a relatively
new research field dealing with the specific interactions of carbohydrates with the immune …

Drug Discovery for Mycobacterium tuberculosis Using Structure-Based Computer-Aided Drug Design Approach

MA Ejalonibu, SA Ogundare, AA Elrashedy… - International Journal of …, 2021 - mdpi.com
Develo** new, more effective antibiotics against resistant Mycobacterium tuberculosis that
inhibit its essential proteins is an appealing strategy for combating the global tuberculosis …

Biosynthesis of Galactan in Mycobacterium tuberculosis as a Viable TB Drug Target?

Z Konyariková, K Savková, S Kozmon, K Mikušová - Antibiotics, 2020 - mdpi.com
While target-based drug design has proved successful in several therapeutic areas, this
approach has not yet provided compelling outcomes in the field of antibacterial agents. This …

Natural and Synthetic Flavonoids as Potent Mycobacterium tuberculosis UGM Inhibitors

SA Villaume, J Fu, I N'Go, H Liang… - … A European Journal, 2017 - Wiley Online Library
This study reports a novel class of inhibitors of uridine 5′‐diphosphate (UDP)
galactopyranose mutase (UGM) derived from a screening of natural products. This enzyme …

In Silico Approach: Anti-Tuberculosis Activity of Caespitate in the H37Rv Strain

A Moreno-Ceballos, NA Caballero, ME Castro… - Current Issues in …, 2024 - mdpi.com
Tuberculosis is a highly lethal bacterial disease worldwide caused by Mycobacterium
tuberculosis (Mtb). Caespitate is a phytochemical isolated from Helichrysum caespititium, a …

Pyrazole and Triazole Derivatives as Mycobacterium tuberculosis UDP-Galactopyranose Inhibitors

DM Ahmed, JM Chen, DAR Sanders - Pharmaceuticals, 2022 - mdpi.com
UDP-galactopyranose mutase (UGM) is an essential enzyme involved in the bacterial cell
wall synthesis, and is not present in mammalian cells. Thus, UGM from Mycobacterium …

Unraveling the unexpected aggregation behavior of Pyrazole-Based compounds Targeting Mycobacterium tuberculosis UDP-Galactopyranose mutase

DM Ahmed, DAR Sanders - Bioorganic & Medicinal Chemistry, 2023 - Elsevier
A pyrazole-based compound, MS208, was previously identified as an inhibitor of UDP-
Galactopyranose Mutase from Mycobacterium tuberculosis (Mt UGM). Targeting this enzyme …

Computational Approach To Evaluate The Potential Of Some Phytocompounds Of Flacourtia Jangomas Against Udp-Glf Enzyme Of Mycobacterium Tuberculosis (Mtb) …

SB Choudhury, MA Laskar… - Journal of …, 2024 - search.ebscohost.com
The ongoing usage of natural products since time immemorial has resulted in several
beneficial medications derived from plant sources. Flavonoids are well known for their anti …

Conformational control of UDP-galactopyranose mutase inhibition

K Wangkanont, VJ Winton, KT Forest, LL Kiessling - Biochemistry, 2017 - ACS Publications
UDP-galactopyranose mutase (Glf or UGM) catalyzes the formation of uridine 5′-
diphosphate-α-d-galactofuranose (UDP-Gal f) from UDP-galactopyranose (UDP-Gal p). The …